In-Process Controls in Pharmaceutical Manufacturing: Importance and Examples

by

Quality is the backbone of the pharmaceutical industry. Every tablet, capsule, vial, or ointment must meet strict standards of identity, strength, purity, safety, and performance before it reaches a patient. But quality is not something that can be checked only at the end of manufacturing. Instead, it must be built into every stage of the process. This is where In-process controls in pharma becomes a critical component of Good Manufacturing Practices (GMP).

In-process controls—commonly known as IPCs—are the checks performed during manufacturing to ensure that the product meets predetermined quality criteria. These controls help detect problems early, prevent deviations, avoid batch failures, reduce rework, and maintain consistent product quality. Regulatory agencies like WHO, FDA, and EMA emphasize IPCs as essential components of a robust pharmaceutical quality management system.

This comprehensive guide explains everything you need to know about In-process controls in pharma, including its importance, objectives, regulatory expectations, parameters, documentation needs, and real-world examples for different dosage forms.

In-process controls in pharma

Table of Contents

What Is In-Process Controls in Pharma?

In-process controls in pharma refers to the checks and tests carried out during various stages of pharmaceutical manufacturing to ensure that processes consistently produce products that meet predefined quality standards. IPCs help monitor, control, and verify critical parameters to detect any variations quickly.

These controls are performed between raw material dispensing and final product packaging and often involve sampling, testing, and adjusting process parameters on the production floor.

According to WHO GMP:

“In-process controls are checks performed during production to monitor and, if necessary, adjust the process to ensure the product conforms to its specifications.”

In simpler terms, IPCs ensure that what is happening inside the manufacturing area is correct, consistent, and under control.

Why In-Process Controls in Pharma Is Important

1. Ensures Consistent Product Quality

Pharmaceutical products must meet strict quality standards. IPCs verify critical parameters during manufacturing to ensure uniformity and consistency in every batch.

2. Prevents Batch Failures

Detecting a deviation early helps prevent large-scale failures, reducing financial losses and ensuring quality.

3. Minimizes Rework and Reprocessing

Timely adjustments during processing reduce the need for costly rework, reprocessing, or rejection.

4. Ensures Regulatory Compliance

Regulatory agencies expect pharmaceutical manufacturers to maintain robust in-process controls to ensure patient safety.

5. Improves Process Understanding

IPCs help manufacturing personnel understand the behavior of processes, raw materials, and equipment.

6. Enhances Efficiency and Productivity

By controlling parameters in real-time, IPCs help optimize workflows and maintain smooth production.

7. Protects Patient Safety

Consistent dosing, strength, and performance ensure that medicines are safe and effective.

Objectives of In-Process Controls in Pharma

The main objectives of In-process controls in pharma include:

  • Ensuring the manufacturing process is within validated parameters

  • Monitoring critical quality attributes (CQAs) throughout production

  • Maintaining product uniformity and consistency

  • Preventing errors and deviations in real-time

  • Ensuring the product meets predefined specifications

  • Supporting a Quality by Design (QbD) approach

  • Complying with GMP and regulatory requirements

These objectives ensure that every stage of manufacturing contributes to the quality of the final product.

Regulatory Expectations for In-Process Controls

Several regulatory guidelines describe the requirements for in-process controls in pharma manufacturing. These include:

1. WHO GMP

WHO emphasizes continuous monitoring and recording IPC results to avoid batch failures.

2. US FDA (21 CFR Part 211)

FDA mandates in-process tests such as weight variation, hardness, potency, and microbial limits, depending on dosage form.

3. EU GMP (EudraLex Volume 4)

EU guidelines expect IPCs to ensure compliance with approved specifications.

4. ICH Guidelines

ICH Q8, Q9, and Q10 outline process understanding, risk management, and quality systems.

Regulatory agencies require:

  • Proper sampling

  • Validated analytical methods

  • Real-time monitoring

  • Documented corrective actions for deviations

  • Traceable and controlled IPC records

Non-compliance can lead to warning letters, recalls, or product rejections.

In-process controls in pharma

Types of In-Process Controls in Pharma

In-process controls can be categorized into several types depending on the stage and purpose.

1. Physical IPCs

Examples:

  • Tablet hardness

  • Weight variation

  • Blend uniformity

  • Granule moisture

  • Capsule fill weight

2. Chemical IPCs

Examples:

  • pH measurement

  • Assay

  • Solvent residue

  • Buffer concentration

3. Microbiological IPCs

Examples:

  • Bioburden

  • Sterility checks

  • Environmental monitoring

4. Process Parameter IPCs

Examples:

  • Mixing time

  • Temperature

  • Compression force

  • Drying time

5. Line Clearance and Equipment Checks

Ensures cleanliness and readiness of equipment before starting production.

Key Stages Where In-Process Controls Are Applied

1. Raw Material Dispensing

  • Weight verification

  • Identity confirmation

  • Calibration checks

2. Granulation

  • Granule moisture

  • Lubrication time

  • Granule flow

  • Particle size

3. Compression (Tablets)

  • Hardness

  • Thickness

  • Weight variation

  • Disintegration time

4. Encapsulation (Capsules)

  • Fill weight

  • Lock length

  • Moisture

5. Coating

  • Weight gain

  • Spray rate

  • Inlet/outlet temperature

6. Liquid/Dry Syrup Manufacturing

  • pH

  • Viscosity

  • Volume accuracy

7. Sterile Manufacturing

  • Particle monitoring

  • Sterility checks

  • Filter integrity testing

Examples of In-Process Controls in Pharma for Different Dosage Forms

This section provides detailed examples to help understand how IPCs function in real-world pharmaceutical manufacturing.

In-Process Controls for Tablets

Tablet manufacturing involves multiple steps—from granulation to compression and coating. These steps require consistent monitoring.

During Granulation

  • Granule moisture content (NMT 2–3%)

  • Bulk density

  • Tapped density

  • Flow properties

During Compression

  • Weight variation

  • Tablet hardness (e.g., 5–8 kg/cm²)

  • Thickness

  • Friability

  • Disintegration time

During Coating

  • Weight gain (e.g., 3–5%)

  • Spray pattern

  • Inlet/outlet temperatures

  • Appearance

In-Process Controls for Capsules

Capsule filling requires precise control to ensure dose uniformity.

Key IPCs

  • Empty capsule inspection

  • Capsule fill weight

  • Moisture content

  • Locking length of capsules

  • Disintegration

  • Weight variation

In-Process Controls for Liquid Dosage Forms

Liquids must meet several quality parameters during manufacturing.

Typical IPCs

  • pH measurement

  • Viscosity

  • Appearance

  • Volume accuracy

  • Temperature

  • Mixing time

In-Process Controls for Sterile Products

Sterile manufacturing is highly sensitive and strictly regulated.

Important IPCs

  • Sterility assurance

  • Bioburden

  • Environmental monitoring

  • Filter integrity test (Bubble Point Test)

  • Fill volume accuracy

  • Container closure integrity

In-Process Controls for Ointments and Creams

Semi-solid dosage forms require monitoring for consistency and stability.

Typical IPCs

  • Viscosity measurement

  • Homogeneity

  • pH

  • Fill volume

  • Appearance

Sampling Procedures for In-Process Controls in Pharma

Effective sampling is essential to ensure accurate results.

Types of Sampling

  • Random sampling

  • Stratified sampling

  • Composite sampling

  • Online/At-line sampling

  • Time-based sampling (e.g., every 30 minutes during compression)

Sampling Tools

  • Powder samplers

  • Thief samplers

  • Tablet picking tools

  • Automated sampling systems

Documentation Requirements for In-Process Controls

Proper documentation ensures traceability and compliance.

Documentation Must Include:

  • Sampling details

  • Analytical test methods

  • Results and observations

  • Deviations and corrective actions

  • Equipment ID

  • Operator signatures

  • Batch numbers

  • Time of testing

Electronic systems like LIMS and MES are increasingly used to manage IPC data.

Trending Technologies in In-Process Controls

Pharma manufacturing is rapidly adopting modern technologies for real-time monitoring.

1. PAT (Process Analytical Technology)

Enables real-time monitoring of critical parameters.

2. NIR Spectroscopy

Used for blend uniformity and moisture content.

3. Automation and SCADA

Enhances accuracy and reduces human error.

4. AI-Based Prediction Models

Helps predict deviations before they occur.

5. IoT Sensors

Used for temperature, humidity, and vibration monitoring.

These technologies strengthen In-process control in pharma and support continuous manufacturing.

Common Challenges in In-Process Controls

1. Human Errors

Incorrect sampling or recording can lead to deviations.

2. Inconsistent Sampling Techniques

Can affect accuracy of results.

3. Equipment Variations

Uncalibrated machines may produce inconsistent results.

4. Environmental Conditions

Temperature or humidity fluctuations can affect product quality.

5. Insufficient Training

Operators must understand the importance of IPCs and regulatory expectations.

Best Practices for Effective In-Process Controls in Pharma

  • Validate all analytical and mechanical equipment

  • Use risk-based sampling

  • Maintain accurate and real-time documentation

  • Implement training programs for staff

  • Use technology-driven systems (PAT, NIR, automation)

  • Review IPC trends to identify early signs of deviations

  • Conduct regular audits and inspections

Conclusion

In-process controls in pharma is an essential part of pharmaceutical manufacturing that ensures consistency, quality, and safety at every step. By performing real-time checks during manufacturing, companies can detect deviations early, avoid batch failures, reduce rework, and comply with global regulatory requirements. IPCs not only protect patient safety but also improve efficiency, productivity, and the overall reliability of pharmaceutical processes.

With technological advancements like PAT, NIR, and automation, IPCs are becoming more accurate, efficient, and predictive—helping the industry shift from reactive quality control to proactive quality assurance.

Implementing robust in-process controls is a must for every pharmaceutical organization committed to delivering high-quality medicines to patients worldwide.

FAQs on In-Process Controls in Pharma

1. What is the meaning of in-process controls in pharma?

It refers to the checks and tests performed during manufacturing to ensure the product meets quality standards before final release.

2. Why is in-process controls important?

It prevents batch failures, ensures uniformity, maintains GMP compliance, and protects patient safety.

3. Who is responsible for IPCs in a pharmaceutical company?

Production and Quality Assurance (QA) teams collectively manage IPC activities.

4. What are common IPC parameters for tablet manufacturing?

Hardness, weight variation, thickness, friability, disintegration, and appearance.

5. Are in-process controls mandatory?

Yes. Regulatory guidelines like WHO, FDA, and EU GMP require IPC implementation.

6. How often are IPCs performed?

Depends on the process—some are performed continuously, others at defined intervals (e.g., every 15 or 30 minutes).

Leave a Comment